Shashkova et al. confirmed that KD3-IFN constructed by introducing the IFN-α gene to KD3 can inhibit tumor growth in subcutaneous xenografts of Hep3B cells from immunodeficient mice compared with KD3 alone, thereby prolonging survival time and reducing hepatotoxicity [67]. The gene discussed is IFNA1; the disease is neoplasm.